Rapid BioSense

Rapid BioSense is a medical technology company specializing in the development of a high-sensitivity electronic biosensor platform for rapid, point-of-care diagnostic testing. The company's proprietary technology enables the direct detection of pathogens and biomarkers from various sample types, delivering laboratory-quality results in minutes without the need for complex sample preparation. Their primary product focus includes rapid tests for infectious diseases such as COVID-19, Influenza A/B, and RSV. By leveraging semiconductor-based sensing, Rapid BioSense aims to provide a scalable and cost-effective solution for decentralized healthcare settings. The platform is designed to be versatile, with potential applications spanning clinical diagnostics, environmental monitoring, and food safety.